In vivo lipopolysaccharide exposure of human blood leukocytes induces cross-tolerance to multiple TLR ligands

Journal of Immunology

Volumn 183, Issue 1, 2009, Pages 533-542

  De Vos, Alex F ^a   Pater, Jennie M ^a   Van Den Pangaart, Petra S ^a   De Kruif, Martijn D ^a   Van 't Veer, Cornelis ^a   Van Der Poll, Tom ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 3; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 7; TUMOR NECROSIS FACTOR; CYTOKINE; LIGAND; TLR2 PROTEIN, HUMAN; TLR3 PROTEIN, HUMAN; TLR5 PROTEIN, HUMAN; TLR7 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 3;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CONCENTRATION (PARAMETERS); CROSS TOLERANCE; CYTOKINE RELEASE; ENDOTOXEMIA; EXPOSURE; GRAM NEGATIVE INFECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; IN VIVO STUDY; LEUKOCYTE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS; SIGNAL TRANSDUCTION; BACILLUS SUBTILIS; BIOSYNTHESIS; CELL CULTURE; DRUG ANTAGONISM; ESCHERICHIA COLI; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; SACCHAROMYCES CEREVISIAE; SECRETION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

ADULT; BACILLUS SUBTILIS; CELLS, CULTURED; CYTOKINES; ESCHERICHIA COLI; HUMANS; IMMUNE TOLERANCE; INJECTIONS, INTRAVENOUS; LEUKOCYTES; LIGANDS; LIPOPOLYSACCHARIDES; MALE; SACCHAROMYCES CEREVISIAE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 5; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTORS;

EID: 68949103827     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0802189     Document Type: Article

References (89)

1. Territo, M. C., and D. W. Golde. 1976. Granulocyte function in experimental human endotoxemia. Blood 47: 539-544.
2. Schultz, M. J., D. P. Olszyna, E. De Jonge, A. Verbon, S. J. van Deventer, and T. van der Poll. 2000. Reduced ex vivo chemokine production by polymorphonuclear cells after in vivo exposure of normal humans to endotoxin. J. Infect. Dis. 182: 1264-1267.
3. Lauw, F. N., T. Ten Hove, P. E. Dekkers, E. De Jonge, S. J. van Deventer, and T. van der Poll. 2000. Reduced Th1, but not Th2, cytokine production by lymphocytes after in vivo exposure of healthy subjects to endotoxin. Infect. Immun. 68: 1014-1018.
4. Granowitz, E. V., R. Porat, J. W. Mier, S. F. Orencole, G. Kaplanski, E. A. Lynch, K. Ye, E. Vannier, S. M. Wolff, and C. A. Dinarello. 1993. Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans. J. Immunol. 151: 1637-1645. (Pubitemid 23219302)
5. van der Poll, T., S. M. Coyle, L. L. Moldawer, and S. F. Lowry. 1996. Changes in endotoxin-induced cytokine production by whole blood after in vivo exposure of normal humans to endotoxin. J. Infect. Dis. 174: 1356-1360.
6. West, M. A., and W. Heagy. 2002. Endotoxin tolerance: A review. Crit. Care Med. 30: S64-S73.
7. Munoz, C., J. Carlet, C. Fitting, B. Misset, J. P. Bleriot, and J. M. Cavaillon. 1991. Dysregulation of in vitro cytokine production by monocytes during sepsis. J. Clin. Invest. 88: 1747-1754.
8. Ertel, W., J. P. Kremer, J. Kenney, U. Steckholzer, D. Jarrar, O. Trentz, and F. W. Schildberg. 1995. Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 85: 1341-1347.
9. McCall, C. E., L. M. Grosso-Wilmoth, K. LaRue, R. N. Guzman, and S. L. Cousart. 1993. Tolerance to endotoxin-induced expression of the interleukin-1 β gene in blood neutrophils of humans with the sepsis syndrome. J. Clin. Invest. 91: 853-861.
10. Wiersinga, W. J., C. van 't Veer, P. S. van den Pangaart, A. M. Dondorp, N. P. Day, S. J. Peacock, and T. van der Poll. 2009. Immunosuppression associated with interleukin-1R-associated-kinase-M upregulation predicts mortality in Gram-negative sepsis (melioidosis). Crit. Care Med. 37: 569-576.
11. Cavaillon, J. M., M. Adib-Conquy, I. Cloez-Tayarani, and C. Fitting. 2001. Immunodepression in sepsis and SIRS assessed by ex vivo cytokine production is not a generalized phenomenon: a review. J. Endotoxin Res. 7: 85-93.
12. Kleinschmidt, S., G. A. Wanner, D. Bussmann, J. P. Kremer, T. Ziegenfuss, M. D. Menger, and M. Bauer. 1998. Proinflammatory cytokine gene expression in whole blood from patients undergoing coronary artery bypass surgery and its modulation by pentoxifylline. Shock 9: 12-20. (Pubitemid 128463869)
13. Majetschak, M., R. Flach, E. Kreuzfelder, V. Jennissen, T. Heukamp, F. Neudeck, K. P. Schmit-Neuerburg, U. Obertacke, and F. U. Schade. 1999. The extent of traumatic damage determines a graded depression of the endotoxin responsiveness of peripheral blood mononuclear cells from patients with blunt injuries. Crit. Care Med. 27: 313-318. (Pubitemid 29113540)
14. Adib-Conquy, M., P. Moine, K. Asehnoune, A. Edouard, T. Espevik, K. Miyake, C. Werts, and J. M. Cavaillon. 2003. Toll-like receptor-mediated tumor necrosis factor and interleukin-10 production differ during systemic inflammation. Am. J. Respir. Crit. Care Med. 168: 158-164.
15. van 't Veer, C., P. S. van den Pangaart, M. A. van Zoelen, M. De Kruif, R. S. Birjmohun, E. S. Stroes, A. F. De Vos, and T. van der Poll. 2007. Induction of IRAK-M is associated with lipopolysaccharide tolerance in a human endotoxemia model. J. Immunol. 179: 7110-7120.
16. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511.
17. Kawai, T., and S. Akira. 2007. Signaling to NF-κB by Toll-like receptors. Trends Mol. Med. 13: 460-469.
18. Liew, F. Y., D. Xu, E. K. Brint, and L. A. O'Neill. 2005. Negative regulation of Toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5: 446-458.
19. Carty, M., R. Goodbody, M. Schroder, J. Stack, P. N. Moynagh, and A. G. Bowie. 2006. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling. Nat. Immunol. 7: 1074-1081.
20. Wang, J. H., M. Doyle, B. J. Manning, Q. Di Wu, S. Blankson, and H. P. Redmond. 2002. Induction of bacterial lipoprotein tolerance is associated with suppression of Toll-like receptor 2 expression. J. Biol. Chem. 277: 36068-36075.
21. Nakayama, K., S. Okugawa, S. Yanagimoto, T. Kitazawa, K. Tsukada, M. Kawada, S. Kimura, K. Hirai, Y. Takagaki, and Y. Ota. 2004. Involvement of IRAK-M in peptidoglycan-induced tolerance in macrophages. J. Biol. Chem. 279: 6629-6634.
22. Siedlar, M., M. Frankenberger, E. Benkhart, T. Espevik, M. Quirling, K. Brand, M. Zembala, and L. Ziegler-Heitbrock. 2004. Tolerance induced by the lipopeptide Pam3Cys is due to ablation of IL-1R-associated kinase-1. J. Immunol. 173: 2736-2745. (Pubitemid 39063135)
23. Sato, S., F. Nomura, T. Kawai, O. Takeuchi, P. F. Muhlradt, K. Takeda, and S. Akira. 2000. Synergy and cross-tolerance between toll-like receptor (TLR) 2- and TLR4-mediated signaling pathways. J. Immunol. 165: 7096-7101. (Pubitemid 32001184)
24. Sato, S., O. Takeuchi, T. Fujita, H. Tomizawa, K. Takeda, and S. Akira. 2002. A variety of microbial components induce tolerance to lipopolysaccharide by differentially affecting MyD88-dependent and -independent pathways. Int. Immunol. 14: 783-791. (Pubitemid 34814639)
25. Lehner, M. D., S. Morath, K. S. Michelsen, R. R. Schumann, and T. Hartung. 2001. Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different Toll-like receptors independent of paracrine mediators. J. Immunol. 166: 5161-5167.
26. Mizel, S. B., and J. A. Snipes. 2002. Gram-negative flagellin-induced self-tolerance is associated with a block in interleukin-1 receptor-associated kinase release from toll-like receptor 5. J. Biol. Chem. 277: 22414-22420.
27. Yeo, S. J., J. G. Yoon, S. C. Hong, and A. K. Yi. 2003. CpG DNA induces self and cross-hyporesponsiveness of RAW264.7 cells in response to CpG DNA and lipopolysaccharide: alterations in IL-1 receptor-associated kinase expression. J. Immunol. 170: 1052-1061.
28. Dalpke, A. H., M. D. Lehner, T. Hartung, and K. Heeg. 2005. Differential effects of CpG-DNA in Toll-like receptor-2/-4/-9 tolerance and cross-tolerance. Immunology 116: 203-212.
29. Li, C. H., J. H. Wang, and H. P. Redmond. 2006. Bacterial lipoprotein-induced self-tolerance and cross-tolerance to LPS are associated with reduced IRAK-1 expression and MyD88-IRAK complex formation. J. Leukocyte Biol. 79: 867-875.
30. Jacinto, R., T. Hartung, C. McCall, and L. Li. 2002. Lipopolysaccharide- and lipoteichoic acid-induced tolerance and cross-tolerance: distinct alterations in IL-1 receptor-associated kinase. J. Immunol. 168: 6136-6141.
31. Dobrovolskaia, M. A., A. E. Medvedev, K. E. Thomas, N. Cuesta, V. Toshchakov, T. Ren, M. J. Cody, S. M. Michalek, N. R. Rice, and S. N. Vogel. 2003. Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-κB signaling pathway components. J. Immunol. 170: 508-519.
32. De Kruif, M. D., L. C. Lemaire, I. A. Giebelen, M. A. van Zoelen, J. M. Pater, P. S. van den Pangaart, A. P. Groot, A. F. De Vos, P. J. Elliott, J. C. Meijers, et al. 2007. Prednisolone dose-dependently influences inflammation and coagulation during human endotoxemia. J. Immunol. 178: 1845-1851.
33. Pajkrt, D., L. Camoglio, M. C. Tiel-van Buul, K. De Bruin, D. L. Cutler, M. B. Affrime, G. Rikken, T. van der Poll, J. W. Ten Cate, and S. J. van Deventer. 1997. Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: effect of timing of recombinant human IL-10 administration. J. Immunol. 158: 3971-3977.
34. Renckens, R., S. Weijer, A. F. De Vos, J. M. Pater, J. C. Meijers, C. E. Hack, M. Levi, and T. van der Poll. 2004. Inhibition of plasmin activity by tranexamic acid does not influence inflammatory pathways during human endotoxemia. Arterioscler. Thromb. Vasc. Biol. 24: 483-488.
35. Morath, S., A. Geyer, and T. Hartung. 2001. Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J. Exp. Med. 193: 393-397.
36. Spek, C. A., A. Verbon, H. Aberson, J. P. Pribble, C. J. McElgunn, T. Turner, T. Axtelle, J. Schouten, T. van Der Poll, and P. H. Reitsma. 2003. Treatment with an anti-CD14 monoclonal antibody delays and inhibits lipopolysaccharide-induced gene expression in humans in vivo. J. Clin. Immunol. 23: 132-140.
37. Lemaire, L. C., M. D. De Kruif, I. A. Giebelen, M. Levi, T. van der Poll, and M. Heesen. 2006. Dobutamine does not influence inflammatory pathways during human endotoxemia. Crit. Care Med. 34: 1365-1371.
38. ++ monocytes are a major source of TNF. J. Immunol. 168: 3536-3542.
39. Wang, J. E., P. F. Jorgensen, M. Almlof, C. Thiemermann, S. J. Foster, A. O. Aasen, and R. Solberg. 2000. Peptidoglycan and lipoteichoic acid from Staphylococcus aureus induce tumor necrosis factor α, interleukin 6 (IL-6), and IL-10 production in both T cells and monocytes in a human whole blood model. Infect. Immun. 68: 3965-3970.
40. Muzio, M., D. Bosisio, N. Polentarutti, G. D'Amico, A. Stoppacciaro, R. Mancinelli, C. van't Veer, G. Penton-Rol, L. P. Ruco, P. Allavena, and A. Mantovani. 2000. Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J. Immunol. 164: 5998-6004.
41. Visintin, A., A. Mazzoni, J. H. Spitzer, D. H. Wyllie, S. K. Dower, and D. M. Segal. 2001. Regulation of Toll-like receptors in human monocytes and dendritic cells. J. Immunol. 166: 249-255.
42. Zarember, K. A., and P. J. Godowski. 2002. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immunol. 168: 554-561.
43. Hayashi, F., T. K. Means, and A. D. Luster. 2003. Toll-like receptors stimulate human neutrophil function. Blood 102: 2660-2669.
44. Hornung, V., S. Rothenfusser, S. Britsch, A. Krug, B. Jahrsdorfer, T. Giese, S. Endres, and G. Hartmann. 2002. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168: 4531-4537.
45. Papadimitraki, E. D., C. Choulaki, E. Koutala, G. Bertsias, C. Tsatsanis, I. Gergianaki, A. Raptopoulou, H. D. Kritikos, C. Mamalaki, P. Sidiropoulos, and D. T. Boumpas. 2006. Expansion of Toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process. Arthritis Rheum. 54: 3601-3611.
46. Kadowaki, N., S. Ho, S. Antonenko, R. W. Malefyt, R. A. Kastelein, F. Bazan, and Y. J. Liu. 2001. Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194: 863-869.
47. Pisegna, S., G. Pirozzi, M. Piccoli, L. Frati, A. Santoni, and G. Palmieri. 2004. p38 MAPK activation controls the TLR3-mediated up-regulation of cytotoxicity and cytokine production in human NK cells. Blood 104: 4157-4164.
48. Jozsef, L., T. Khreiss, D. El Kebir, and J. G. Filep. 2006. Activation of TLR-9 induces IL-8 secretion through peroxynitrite signaling in human neutrophils. J. Immunol. 176: 1195-1202.
49. Greisman, S. E., E. J. Young, and F. A. Carozza, Jr. 1969. Mechanisms of endotoxin tolerance: V. Specificity of the early and late phases of pyrogenic tolerance. J. Immunol. 103: 1223-1236.
50. Cross, A. S. 2002. Endotoxin tolerance-current concepts in historical perspective. J. Endotoxin Res. 8: 83-98.
51. Copeland, S., H. S. Warren, S. F. Lowry, S. E. Calvano, and D. Remick. 2005. Acute inflammatory response to endotoxin in mice and humans. Clin. Diagn. Lab. Immunol. 12: 60-67.
52. Oshiumi, H., M. Matsumoto, K. Funami, T. Akazawa, and T. Seya. 2003. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-β induction. Nat. Immunol. 4: 161-167.
53. Hoebe, K., X. Du, P. Georgel, E. Janssen, K. Tabeta, S. O. Kim, J. Goode, P. Lin, N. Mann, S. Mudd, K. Crozat, S. Sovath, J. Han, and B. Beutler. 2003. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424: 743-748.
54. Yamamoto, M., S. Sato, K. Mori, K. Hoshino, O. Takeuchi, K. Takeda, and S. Akira. 2002. A novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-β promoter in the Toll-like receptor signaling. J. Immunol. 169: 6668-6672.
55. Kawai, T., S. Sato, K. J. Ishii, C. Coban, H. Hemmi, M. Yamamoto, K. Terai, M. Matsuda, J. Inoue, S. Uematsu, O. Takeuchi, and S. Akira. 2004. Interferon-α induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat. Immunol. 5: 1061-1068.
56. Honda, K., H. Yanai, H. Negishi, M. Asagiri, M. Sato, T. Mizutani, N. Shimada, Y. Ohba, A. Takaoka, N. Yoshida, and T. Taniguchi. 2005. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434: 772-777.
57. Uematsu, S., and S. Akira. 2007. Toll-like receptors and type I interferons. J. Biol. Chem. 282: 15319-15323.
58. Smith, R. L., T. W. Chong, M. G. Hughes, T. L. Hedrick, H. L. Evans, S. T. McElearney, A. R. Saalwachter, D. P. Raymond, K. Du, C. K. Rudy, T. L. Pruett, and R. G. Sawyer. 2004. Impact of immunomodulatory oligodeoxynucleotides on cytokine production in the lipopolysaccharide-stimulated human whole blood model. Surgery 136: 464-472.
59. De Wit, D., S. Tonon, V. Olislagers, S. Goriely, M. Boutriaux, M. Goldman, and F. Willems. 2003. Impaired responses to Toll-like receptor 4 and Toll-like receptor 3 ligands in human cord blood. J. Autoimmun. 21: 277-281.
60. Yang, K., A. Puel, S. Zhang, C. Eidenschenk, C. L. Ku, A. Casrouge, C. Picard, H. Von Bernuth, B. Senechal, S. Plancoulaine, et al. 2005. Human TLR-7-, -8-, and -9-mediated induction of IFN-α/β and -λ is IRAK-4 dependent and redundant for protective immunity to viruses. Immunity 23: 465-478.
61. Jiang, Z., P. Georgel, X. Du, L. Shamel, S. Sovath, S. Mudd, M. Huber, C. Kalis, S. Keck, C. Galanos, et al. 2005. CD14 is required for MyD88-independent LPS signaling. Nat. Immunol. 6: 565-570.
62. Bowie, A. G. 2008. TRIM-ing down Tolls. Nat. Immunol. 9: 348-350.
63. Siegal, F. P., N. Kadowaki, M. Shodell, P. A. Fitzgerald-Bocarsly, K. Shah, S. Ho, S. Antonenko, and Y. J. Liu. 1999. The nature of the principal type 1 interferon-producing cells in human blood. Science 284: 1835-1837. (Pubitemid 29275623)
64. Cao, W., and Y. J. Liu. 2007. Innate immune functions of plasmacytoid dendritic cells. Curr. Opin. Immunol. 19: 24-30.
65. Ito, T., H. Kanzler, O. Duramad, W. Cao, and Y. J. Liu. 2006. Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells. Blood 107: 2423-2431.
66. Ida, J. A., N. Shrestha, S. Desai, S. Pahwa, W. A. Hanekom, and P. A. Haslett. 2006. A whole blood assay to assess peripheral blood dendritic cell function in response to Toll-like receptor stimulation. J. Immunol. Methods 310: 86-99.
67. Ito, T., R. Amakawa, T. Kaisho, H. Hemmi, K. Tajima, K. Uehira, Y. Ozaki, H. Tomizawa, S. Akira, and S. Fukuhara. 2002. Interferon-α and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets. J. Exp. Med. 195: 1507-1512.
68. - type 2 dendritic cell precursors and CD11c dendritic cells to produce type I IFN. J. Immunol. 166: 2291-2295.
69. Karp, C. L., M. Wysocka, X. Ma, M. Marovich, R. E. Factor, T. Nutman, M. Armant, L. Wahl, P. Cuomo, and G. Trinchieri. 1998. Potent suppression of IL-12 production from monocytes and dendritic cells during endotoxin tolerance. Eur. J. Immunol. 28: 3128-3136.
70. Yoza, B. K., J. Y. Hu, S. L. Cousart, and C. E. McCall. 2000. Endotoxin inducible transcription is repressed in endotoxin tolerant cells. Shock 13: 236-243.
71. Foster, S. L., D. C. Hargreaves, and R. Medzhitov. 2007. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447: 972-978.
72. Chan, C., L. Li, C. E. McCall, and B. K. Yoza. 2005. Endotoxin tolerance disrupts chromatin remodeling and NF-κB transactivation at the IL-1β promoter. J. Immunol. 175: 461-468.
73. Shi, M., W. Deng, E. Bi, K. Mao, Y. Ji, G. Lin, X. Wu, Z. Tao, Z. Li, X. Cai, S. Sun, C. Xiang, and B. Sun. 2008. TRIM30α negatively regulates TLR-mediated NF-κB activation by targeting TAB2 and TAB3 for degradation. Nat. Immunol. 9: 369-377.
74. Cuschieri, J., J. Billigren, and R. V. Maier. 2006. Endotoxin tolerance attenuates LPS-induced TLR4 mobilization to lipid rafts: a condition reversed by PKC activation. J. Leukocyte Biol. 80: 1289-1297.
75. Piao, W., C. Song, H. Chen, L. M. Wahl, K. A. Fitzgerald, L. A. O'Neill, and A. E. Medvedev. 2008. Tyrosine phosphorylation of MyD88 adapter-like (Mal) is critical for signal transduction and blocked in endotoxin tolerance. J. Biol. Chem. 283: 3109-3119.
76. Medvedev, A. E., A. Lentschat, L. M. Wahl, D. T. Golenbock, and S. N. Vogel. 2002. Dysregulation of LPS-induced Toll-like receptor 4-MyD88 complex formation and IL-1 receptor-associated kinase 1 activation in endotoxin-tolerant cells. J. Immunol. 169: 5209-5216.
77. Medvedev, A. E., W. Piao, J. Shoenfelt, S. H. Rhee, H. Chen, S. Basu, L. M. Wahl, M. J. Fenton, and S. N. Vogel. 2007. Role of TLR4 tyrosine phosphorylation in signal transduction and endotoxin tolerance. J. Biol. Chem. 282: 16042-16053.
78. Fujihara, M., S. Wakamoto, T. Ito, M. Muroi, T. Suzuki, H. Ikeda, and K. Ikebuchi. 2000. Lipopolysaccharide-triggered desensitization of TNF-α mRNA expression involves lack of phosphorylation of IκBα in a murine macrophage-like cell line, P388D1. J. Leukocyte Biol. 68: 267-276.
79. Li, L., S. Cousart, J. Hu, and C. E. McCall. 2000. Characterization of interleukin-1 receptor-associated kinase in normal and endotoxin-tolerant cells. J. Biol. Chem. 275: 23340-23345.
80. Learn, C. A., S. B. Mizel, and C. E. McCall. 2000. mRNA and protein stability regulate the differential expression of pro- and anti-inflammatory genes in endotoxin-tolerant THP-1 cells. J. Biol. Chem. 275: 12185-12193.
81. Han, J., and R. J. Ulevitch. 2005. Limiting inflammatory responses during activation of innate immunity. Nat. Immunol. 6: 1198-1205.
82. Naka, T., M. Fujimoto, H. Tsutsui, and A. Yoshimura. 2005. Negative regulation of cytokine and TLR signalings by SOCS and others. Adv. Immunol. 87: 61-122.
83. Kobayashi, K., L. D. Hernandez, J. E. Galan, C. A. Janeway, Jr., R. Medzhitov, and R. A. Flavell. 2002. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110: 191-202.
84. Swantek, J. L., M. F. Tsen, M. H. Cobb, and J. A. Thomas. 2000. IL-1 receptor-associated kinase modulates host responsiveness to endotoxin. J. Immunol. 164: 4301-4306.
85. Suzuki, N., S. Suzuki, G. S. Duncan, D. G. Millar, T. Wada, C. Mirtsos, H. Takada, A. Wakeham, A. Itie, S. Li, et al. 2002. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 416: 750-756.
86. Uematsu, S., S. Sato, M. Yamamoto, T. Hirotani, H. Kato, F. Takeshita, M. Matsuda, C. Coban, K. J. Ishii, T. Kawai, O. Takeuchi, and S. Akira. 2005. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-α induction. J. Exp. Med. 201: 915-923.
87. Kim, T. W., K. Staschke, K. Bulek, J. Yao, K. Peters, K. H. Oh, Y. Vandenburg, H. Xiao, W. Qian, T. Hamilton, et al. 2007. A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity. J. Exp. Med. 204: 1025-1036.
88. Kawagoe, T., S. Sato, A. Jung, M. Yamamoto, K. Matsui, H. Kato, S. Uematsu, O. Takeuchi, and S. Akira. 2007. Essential role of IRAK-4 protein and its kinase activity in Toll-like receptor-mediated immune responses but not in TCR signaling. J. Exp. Med. 204: 1013-1024.
89. Escoll, P., C. Del Fresno, L. Garcia, G. Valles, M. J. Lendinez, F. Arnalich, and E. Lopez-Collazo. 2003. Rapid up-regulation of IRAK-M expression following a second endotoxin challenge in human monocytes and in monocytes isolated from septic patients. Biochem. Biophys. Res. Commun. 311: 465-472.